These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 13540175

  • 1. [Clinical experiences with BCM (degranol) beta-bis-chlorethylamino-D-mannitoldichlorhydrate].
    ECKHARDT A, SELLEI C, MOLNAR A, HARTAI F.
    Krebsarzt; 1958 Feb; 13(2):73-5. PubMed ID: 13540175
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Pre- and post-operative dosage of degranol in operable cancer patients].
    RUBANYI P, SZEKELY J, NEMETH E.
    Magy Seb; 1959 Mar; 12(1):65-8. PubMed ID: 13643065
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical trials of mechlorethamine-N-oxide in therapy of tumors].
    SELLEI C, ECKHARDT A.
    Munch Med Wochenschr; 1958 May 09; 100(19):784-6. PubMed ID: 13565952
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical studies on a cytostatic mannitol derivative (BCM)].
    ECKHARDT S, HARTAI F, MOLNAR E, SELLEI C.
    Orv Hetil; 1956 Sep 02; 97(36):999-1001. PubMed ID: 13388313
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical trials of a new nitrogen mustard, MX 101].
    IZARN P, POURQUIER H, GARY-BOBO J, PUJOL H, EMBERGER JM.
    Montp Med; 1960 Nov 02; 58():178-83. PubMed ID: 13718407
    [No Abstract] [Full Text] [Related]

  • 12. [Studies on the inhibiting effect of a new nitrogen mustard derivative, 1, 6-bis(beta-chloraethylamino)-1, 6-desoxy-D-mannitol dihydrochloride (BCM), on tumor growth].
    KELLNER B, NEMETH L.
    Orv Hetil; 1956 Sep 02; 97(36):981-4. PubMed ID: 13388307
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pathological and clinical effects of 1.6-bis(beta-chloraethylamino)-1.6-desoxy-D-mannite-dichlorhydrate/BCM.
    KELLNER B, NEMETH L, SELLEI C.
    Acta Unio Int Contra Cancrum; 1957 Sep 02; 13(3):473-9. PubMed ID: 13469609
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical experiences with nitrogen mustards. V. Therapy of malignant tumors].
    CERNIK F, LUKL P, PROCHAZKA J, VIZDA J.
    Cas Lek Cesk; 1952 Jan 11; 91(2):44-9. PubMed ID: 14390080
    [No Abstract] [Full Text] [Related]

  • 18. [Cytostatic drugs in the treatment of malignant tumors; clinical experiences with mitomen].
    APEL G, KLAGES K.
    Medizinische; 1957 Mar 02; (9):314-8. PubMed ID: 13430178
    [No Abstract] [Full Text] [Related]

  • 19. [Experiences with clinical use of some new chemotherapeutics in tumor therapy].
    PEREVODCHIKOVA NJ.
    Dtsch Med Wochenschr; 1958 Jan 03; 83(1):21-3. PubMed ID: 13500993
    [No Abstract] [Full Text] [Related]

  • 20. [Observations on three years of clinical experience with nitrogen mustard].
    CUCINOTTA U.
    G Ital Chemioter; 1954 Jan 03; 1(1):175-7. PubMed ID: 13191617
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.